Learn

General practitioners play a vital role in addressing the alarming reality that one-third of Australian children first present with life-threatening diabetic ketoacidosis, while many adults endure prolonged metabolic decompensation due to frequent misdiagnosis as having type 2 diabetes.

By engaging with this education, you will learn to accurately classify patients using the international three-stage framework, implement proactive shared-care monitoring plans that recognise urgent red flags, and utilise person-first communication strategies to effectively support families facing the significant psychosocial burden of a type 1 diabetes risk identification.

Learning Outcomes

1. Identify individuals at increased risk of T1D and determine when islet autoantibody testing is clinically indicated.
2. Apply the internationally recognised staging framework for early-stage T1D (Stages 1–3) to support accurate classification and timely action.
3. Develop and implement an appropriate monitoring and referral plan for children and adults with islet autoimmunity.
4. Communicate risk and uncertainty clearly to individuals and families to support preparedness and psychosocial wellbeing.

Details

Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy